Clinical Trial Update: Metabolic Changes Induced by NMN in Healthy Subjects With Acute Binge Drink [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating metabolic effects of nicotinamide mononucleotide (NMN) in healthy subjects after acute binge drinking; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Steatosis
• Liver Injury

Drugs mentioned

• NMN (nicotinamide mononucleotide)

Snippet

Sponsor: Zhejiang Chinese Medical University | Conditions: Binge Drinking, Liver Injury | Phase 1, Phase 2 | Status: COMPLETED